DTRA Priorities and Initiatives

Priority Areas as a Framework for 12 Initiatives to Drive Decentralized Research through Collaboration

To accomplish our mission to accelerate the adoption of patient-focused decentralized clinical trials and research, our DTRA Organizational Members have defined four Priority areas as a framework for twelve new Initiatives which will serve as the foundation for collaboration of our stakeholders.

Priorities and Initiatives

Why Join DTRA?

DTRA Organizational Members share reasons for joining our unique Alliance focused on accelerating the adoption of decentralized clinical research.

With more than 100 Organizational Members, DTRA is driving the future of decentralized clinical research.

DTRA Organizational Membership 

Decentralized Trials & Research Alliance Members represent the diverse ecosystem required to support the adoption of decentralized research methods. 

Organizational Members include pharmaceutical and biotechnology companies, regulatory authorities, patient/advocacy organizations, clinical research organizations, technology companies, specialized service providers, investigator site networks, consulting organizations, and other stakeholders.

If you are interested in learning more about becoming an Organizational Member of DTRA, we invite you to explore the many benefits of membership today.